Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

FibroGen Cash on Hand 2013-2025 | FGEN

FibroGen cash on hand from 2013 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
FibroGen Annual Cash on Hand
(Millions of US $)
2024 $50
2023 $203
2022 $422
2021 $405
2020 $687
2019 $534
2018 $621
2017 $736
2016 $253
2015 $181
2014 $180
2013 $123
2012 $40
FibroGen Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $34
2024-12-31 $50
2024-09-30 $131
2024-06-30 $141
2024-03-31 $178
2023-12-31 $203
2023-09-30 $251
2023-06-30 $336
2023-03-31 $356
2022-12-31 $422
2022-09-30 $409
2022-06-30 $438
2022-03-31 $428
2021-12-31 $405
2021-09-30 $486
2021-06-30 $507
2021-03-31 $544
2020-12-31 $687
2020-09-30 $688
2020-06-30 $686
2020-03-31 $535
2019-12-31 $534
2019-09-30 $629
2019-06-30 $661
2019-03-31 $565
2018-12-31 $621
2018-09-30 $653
2018-06-30 $672
2018-03-31 $704
2017-12-31 $736
2017-09-30 $730
2017-06-30 $359
2017-03-31 $243
2016-12-31 $253
2016-09-30 $242
2016-06-30 $231
2016-03-31 $173
2015-12-31 $181
2015-09-30 $222
2015-06-30 $249
2015-03-31 $143
2014-12-31 $180
2014-09-30
2014-06-30
2014-03-31
2013-12-31 $123
2012-12-31 $40
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.024B $0.030B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Zoetis (ZTS) United States $71.977B 26.85
Takeda Pharmaceutical (TAK) Japan $47.379B 9.42
Daiichi Sankyo, - (DSNKY) Japan $45.180B 23.16
BeOne Medicines - (ONC) Cayman Islands $27.838B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.876B 0.00
Merck (MKKGY) Germany $16.572B 12.14
Summit Therapeutics (SMMT) United States $14.742B 0.00
Shionogi (SGIOY) Japan $14.496B 14.52
United Therapeutics (UTHR) United States $12.940B 11.45
Neurocrine Biosciences (NBIX) United States $12.359B 42.33
Orion OYJ (ORINY) Finland $10.283B 27.81
IPSEN (IPSEY) France $10.093B 0.00
Corcept Therapeutics (CORT) United States $7.619B 61.94
Stevanato Group S.p.A (STVN) Italy $7.299B 44.63
Madrigal Pharmaceuticals (MDGL) United States $6.208B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.911B 0.00
Hypermarcas (HYPMY) Brazil $3.177B 20.90
Crinetics Pharmaceuticals (CRNX) United States $2.888B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.832B 9.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.476B 13.39
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.967B 0.00
Indivior (INDV) United States $1.899B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $1.683B 0.00
ARS Pharmaceuticals (SPRY) United States $1.456B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.234B 0.00
Harrow (HROW) United States $1.116B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.069B 21.38
Verve Therapeutics (VERV) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $0.946B 5.10
Akebia Therapeutics (AKBA) United States $0.919B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Ardelyx (ARDX) United States $0.849B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Xencor (XNCR) United States $0.591B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.33
Altimmune (ALT) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.530B 0.00
Relay Therapeutics (RLAY) United States $0.525B 0.00
Bioventus (BVS) United States $0.522B 13.23
AleAnna (ANNA) United States $0.491B 0.00
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Tourmaline Bio (TRML) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.450B 9.40
Oruka Therapeutics (ORKA) United States $0.448B 0.00
Organogenesis (ORGO) United States $0.397B 0.00
Savara (SVRA) United States $0.353B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 9.26
Liminatus Pharma (LIMN) United States $0.333B 0.00
Aquestive Therapeutics (AQST) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.22
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
ProKidney (PROK) United States $0.251B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Esperion Therapeutics (ESPR) United States $0.216B 0.00
MediWound (MDWD) Israel $0.214B 0.00
OmniAb (OABI) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Aclaris Therapeutics (ACRS) United States $0.152B 0.00
Galectin Therapeutics (GALT) United States $0.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.151B 0.00
Journey Medical (DERM) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 18.30
Nektar Therapeutics (NKTR) United States $0.108B 0.00
Achieve Life Sciences (ACHV) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.087B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Surrozen (SRZN) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Telomir Pharmaceuticals (TELO) United States $0.055B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00